Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Variants in NOS2 and CCL2 Modulate Risk of Post-COVID-19 Hyperglycemia via Immune-Metabolic Interactions.

BioMed research international - 1 Jan 2026

Chaimaha Ganyalak, Teerawattanapong Nipaporn, Chaithaisong Kaweeraphat, Narkdontri Tassanee, Songlilitchuwong Suavaluk, Innang Saranya, Suthon Sarocha, Micieli Alessia, Tangjittipokin Watip

Abstract excerpt

Hyperglycemia has increasingly been recognized among individuals recovering from coronavirus disease 2019 (COVID-19); the host factors contributing to heterogeneous metabolic outcomes remain poorly understood. This cohort study investigated the association between innate immune genetic polymorphisms and hyperglycemia in post-COVID-19 patients. A total of 471 adults with previous mild-to-moderate COVID-19 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Chemokine CCL2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to COVID-19

Share to Hyperglycemia

Share to Immunity, Innate

Share to Nitric Oxide Synthase Type II

Share to Risk Factors

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 42528484
DOI: 10.1155/bmri/7994653
PMCID: PMC13420197

Genes

CCL2
NOS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Variants in NOS2 and CCL2 Modulate Risk of Post-COVID-19 Hyperglycemia via Immune-Metabolic Interactions.PMID 42528484Read ↗

Genetic determinants of metabolic-inflammatory dysregulation and machine learning prediction of COVID-19.Semantic proximity Read ↗

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.Semantic proximity Read ↗

Shared genetic mechanism between type 2 diabetes and COVID-19 using pathway-based association analysisSemantic proximity Read ↗

GWAS-Identified Loci are Associated with Obesity and Type 2 Diabetes Mellitus in Patients with Severe COVID-19.Semantic proximity Read ↗

ACE2 polymorphisms impact COVID-19 severity in obese patients.Semantic proximity Read ↗

Bidirectional causal associations between type 2 diabetes and COVID-19.Semantic proximity Read ↗

Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.Semantic proximity Read ↗

Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic RiskSemantic proximity Read ↗

Cytokine profiles, genetic polymorphisms, and systemic inflammatory markers in type 1 diabetes patients with COVID-19: IL-18 a predictor of disease severity.Semantic proximity Read ↗

Anti-SARS-CoV2 antibody levels predict outcome in diabetic patients with COVID-19: a prospective cohort studySemantic proximity Read ↗

Common genetic variants and pathways in diabetes and associated complications and vulnerability of populations with different ethnic origins.Semantic proximity Read ↗

Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.